CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled / 50 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06615388
NCT06615388N/ACompletedOn Track (2.3/mo)Completion was 6mo ago

Low Energy Availability and Cardiovascular Disease

Liverpool Hope University·observational·Posted Sep 26, 2024·Updated Jun 17, 2026

In Brief

An observational study for Low Energy Availability and Cardiovascular Diseases. Completed, enrolled 50 participants across 1 site.

Detailed Summary

Low energy availability (LEA) signifies a condition where the body lacks sufficient energy to support essential physiological functions crucial for maintaining optimal health (1). This energy insufficiency can be exacerbated by the demands of sports and exercise, resulting in negative impacts on various physiological, psychological, and sports performance (11, 8, 2). While LEA is commonly associated with cardiovascular abnormalities, such as early atherosclerosis, endothelial dysfunction, and lower blood pressure, the existing body of research faces limitations, including small sample sizes and primarily exploratory approaches (2). Additionally, despite a growing body of evidence suggesting a strong link between DNA methylation (an epigenetic modification influencing gene expression by tagging specific parts of the DNA code) and cardiovascular disease (9, 6), there has been no prior investigation exploring the interplay between DNA methylation, cardiovascular disease, and LEA. To better understand LEA and its effects on cardiovascular health, it is imperative to address these limitations through further research. Utilising more comprehensive markers of cardiovascular disease and expanding the scope of investigations will contribute to a great understanding of LEA and its implications on cardiovascular health (10).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom

Timeline

N/ACompletedFinished
20252026
First PostedSep 26, 2024
Enrollment StartSep 10, 2024
Primary CompletionDec 13, 2025
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 1.8 years ago

Arms & Interventions

Physically active femalesother

Physically active females with and with low energy availability